<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Marazza, Alessandro</dc:creator>
  <dc:creator>Galli, Carmela</dc:creator>
  <dc:creator>Fasana, Elisa</dc:creator>
  <dc:creator>Sgrignani, Jacopo</dc:creator>
  <dc:creator>Burda, Patricie</dc:creator>
  <dc:creator>Enrico M. A. Fassi</dc:creator>
  <dc:creator>Matthias Baumgartner</dc:creator>
  <dc:creator>Andrea Cavalli</dc:creator>
  <dc:creator>Maurizio Molinari</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Hunter’s syndrome (mucopolysaccharidosis type II) is a rare X-linked lysosomal storage disorder  caused by mutations in the iduronate 2-sulfatase (IDS) gene. Motivated by the case of a child affected  by this syndrome, we compared the intracellular fate of wild type IDS (IDSWT) and of four nonsense  mutations of IDS (IDSL482X, IDSY452X, IDSR443X and IDSW337X) generating progressively shorter  forms of IDS associated with mild to severe forms of the disease. Our analyses revealed formylation of  all forms of IDS at cysteine 84, which is a pre-requisite for enzymatic activity. After formylation, IDSWT  was transported within lysosomes, where it was processed in the mature form of the enzyme. The  length of disease-causing deletions correlated with gravity of the folding and transport phenotype, which  was anticipated by molecular dynamics analyses. The shortest form of IDS, IDSW337X, was retained in  the endoplasmic reticulum (ER) and degraded by the ubiquitin-proteasome system. IDSR443X,  IDSY452X, IDSL482X passed ER quality control, were transported to the lysosomes, but failed  lysosomal quality control resulting in their rapid clearance and in loss-of-function phenotype. Failure of  ER quality control inspection is an established cause of loss-of-function observed in protein misfolding  diseases. Our data reveal that fulfillment of ER requirements might not be sufficient, highlight lysosomal  quality control as the distal station to control lysosomal enzymes fitness and pave the way for  alternative therapeutic interventions.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319181</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319181</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319181/files/Marazza_preprint_2019.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1089/dna.2019.5221</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319181</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Endoplasmic reticulum</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Formylation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Glycosaminoglycans</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Hunter’s disease</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Iduronate-2 sulfatase</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Nonsense mutations</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Lysosomal storage diseases</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Lysosome</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Molecular dynamics</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Mucopolysaccharidosis type II</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns11="xml" ns11:lang="en">Endoplasmic reticulum and lysosomal quality control of four nonsense mutants of iduronate 2-sulfatase linked to Hunter’s syndrome</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_816b</dc:type>
</oai_dc:dc>
